Pursuant to the provisions of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jagsonpal Pharmaceuticals has informed that it enclosed copies of advertisement published on January 22, 2026, in ‘Business Standard’ (English) and ‘Business Standard’ (Hindi) newspaper providing Extracts of Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025.
The above information is a part of company’s filings submitted to BSE.